Abstract
Mononuclear cell infiltration is a common feature of many types of human cancers. In fact, its occurrence is considered so unremarkable that there are no systematic studies describing the prevalence or intensity of infiltrates by tumor type or stage. Instead, it is generally asserted that intense infiltrates are associated with certain tumor types, such as medullary carcinoma of the breast and malignant melanoma (1,2), and that most other cancers are also infiltrated to differing extents. Even without an “epidemiology” of tumor-related inflammatory infiltrates, tumor biologists have extensively focused on this phenomenon for more than 100 yr.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Underwood, J. C. E. 1974. Lymphoreticular infiltration in human tumors: prognostic and biological implications: a review. Br. J. Cancer 30: 538–548.
Underwood, J. C. E., and I. Cam 1972. The ultrastructure of the lymphoreticular cells in non-lymphoid human neoplasms. Virchows Arch. Abt. B Zellpath. 12: 39–50.
Virchow, R. 1863. Die krankhaften Geschwulste. Dreißig Vorlesungen, gehalten während des Wintersemesters 1872–1863 an der Universität zu Berlin. Vorlesungen uber Pathologie, Verlag von August Hirschwald, Berlin.
Waldeyer, H. W. G. 1872. Die entwicklung der carcinome. Virchows Arch. Path. Anat. 55–67.
Jensen, C. O. 1903. Experimentelle untersuchungen über krebs bei mäusen. Zentralbl. f Bakt. Parasit. Infekt. I Abt. Originale. 34: 122–143.
Bashford, E. F. 1905. The growth of cancer under natural and experimental conditions. In: E. F. Bashford, J. A. Murray, and W. Cramer (eds.), Scientific Reports on the Investigations of the ICRF, No. 2 part II. Imperial Cancer Research Fund, London.
Russell, B. R. G. 1908. The nature of resistance to the inoculation of cancer. Third Sci. Rep. ICRF 3: 341–358.
Da Fano, C. 1911. A cytological analysis of the reaction in animals resistant to implanted carcinomata. Fifth Sci. Rep. ICRF 5: 57–75.
Monis, B., and Weinberg, T. 1960. Cytochemical study of esterase activity of human neoplasms and stromal macrophages. Cancer 14: 369–377.
Wade, H. 1980. An experimental investigation of infective sarcoma of the dog, with a consideration of its relationship to cancer. J. Pathol. Bacteriol. 12: 384–425.
Ehrlich, P. 1907. Experimentelle studien an mäustumoren. Zeitschr. f Krebsforschung 5: 59–81.
Burg, G., and Braun-Falco, O. 1972. The cellular stromal reaction in malignant melanoma: a cytochemical investigation. Arch. Derm. Forsch. 245: 318–333.
Carr, I., and J. C. E. Underwood. 1974. The ultrastructure of the local cellular reaction to neoplasia. Int. Rev. Cytol. 37: 329–347.
Göttlinger, H. G., P. Rieber, J. M. Gokel, K. J. Lohe, and G. Riethmüller. 1985. Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int. J. Cancer 35: 199–205.
van Ravenswaay Claasen, H. H., P. M. Kluin, and G. J. Fleuren. 1992. Tumor infiltrating cells in human cancer: on the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab. Invest. 67: 166–174.
Evans, R. 1972. Macrophages in syngeneic animal tumors. Transplantation 14: 468–473.
Cohen, P. J., M. T. Lotze, J. R. Roberts, S. A. Rosenberg, and E. S. Jaffe. 1987. The immunopathology of sequential tumor biopsies in patients treated with interleukin-2: correlation of response with T-cell infiltration and HLA-DR expression. Am. J. Pathol. 129: 208–216.
Gauci, C. L., and P. Alexander. 1975. The macrophage content of some human tumors. Cancer Lett. 1: 29–32.
Eccles, S. A., and P. Alexander. 1974. Macrophage content of tumors in relation to metastatic spread and host immune reaction. Nature 250: 667 - 669.
Berg, J. W. 1959. Inflammation and prognosis in breast cancer: a search for host resistance. Cancer 12: 714–720.
Black, M. M., S. R. Opler, and F. D. Speer. 1955. Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg. Gynecol. Obstet. 100: 543–551.
Champion, H. R., I. W. J. Wallace, and R. J. Prescott. 1972. Histology in breast cancer diagnosis. Br. J. Cancer 26: 129–138.
Takahashi, K. 1961. Squamous cell carcinoma of the esophagus: stromal inflammatory cell infiltration as a prognostic factor. Cancer 14: 921–933.
Lauder, I., and W. Aherne. 1972. The significance of lymphocytic infiltrate in neuroblastoma. Br. J. Cancer 26: 321–330.
Barber, H. R. K., S. C. Sommers, R. Snyder, and T. H. Kwon. 1975. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer. Am. J. Obstet. Gynecol. 121: 795–807.
Fidler, I. J. 1974 Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res. 34: 1074–1078.
Dullens, H. F. J., and W. Den Otter. 1974. Therapy with allogeneic immune peritoneal cells. Cancer Res. 34: 1726–1730.
Keller, R. 1976. Promotion of tumor growth in vivo by antimacrophage agents. J. Natl. Cancer Inst. 57: 1355–1361.
Prehn, R. T. 1972. The immune reaction as a stimulator of tumor growth. Science 176: 170, 171.
Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13: 265–270.
Carrel, A. 1922. Growth-promoting function of leukocytes. J. Exp. Med. 36: 385–391.
Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625–4629.
Bottazzi, B., N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona, and A. Mantovani. 1983. Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210–212.
Bottazzi, B., P. Ghezzi, G. Tarboletti, M. Salmona, N. Colombo, C. Bonazzi, C. Mangioni, and A. Mantovani. 1985. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int. J. Cancer 36: 167–173.
Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27: 4162–4168.
Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, J. I. Kuratsu, and E. J. Leonard. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169: 1449–1459.
Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169: 1485–1490.
Bottazzi, B., F. Colotta, A. Sica, N. Nobili, and A. Mantovani. 1990. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int. J. Cancer 45: 795–797.
Graves, D. T., Y. L. Jiang, M. J. Williamson, and A. J. Valente. 1989. Identification of monocyte chemotactic activity produced by malignant cells. Science 245: 1490–1493.
Cochran, B. H., A. C. Reffel, and C. D. Stiles. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939–947.
Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85: 3738–3742.
Rollins, B. J., P. Stier, T. E. Ernst, and G. G. Wong. 1989. The human homologue of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9: 4687–4695.
Ernst, C. A., Y. J. Zhang, P. R. Hancock, B. J. Rutledge, C. L. Corless, and B. J. Rollins. 1994. Biochemical and biological characterization of murine MCP-1: identification of two functional domains. J. Immunol. 152: 3541–3549.
Mazzucchelli, L., P. Loetscher, A. Kappeler, M. Uguccioni, M. Baggiolini, J. A. Laissue, and C. Mueller. 1996. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasie and prostate adenocarcinoma. Am. J. Pathol. 149 (2): 501–509.
Zachariae, C. O. C., A. O. Anderson, H. L. Thompson, E. Appella, A. Mantovani, J. J. Oppenheim, and K. Matsushima. 1990. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 171: 2177–2182.
Rutledge, B. J., H. Rayburn, R. Rosenberg, R. J. North, R. P. Gladue, C. L. Corless, and B. J. Rollins. 1995. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155: 4838–4843.
Simonet, W. S., T. M. Hughes, H. Q. Nguyen, L. D. Trebasky, D. M. Danilenko, and E. S. Medlock. 1994. Long-term impairment of neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 94: 1310–1319.
Hechtman, D. H., M. I. Cybulsky, H. J. Fuchs, J. B. Baker, and M. A. Gimbrone. 1991. Intravascular IL-8. inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147: 883–892.
Ley, K., J. B. Baker, M. I. Cybulsky, M. A. Gimbrone, and F. W. Luscinskas. 1993. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric vessels without altering L-selectin expression or leukocyte rolling. J. Immunol. 151: 6347–6357.
Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158: 4129–4136.
Chensue, S. W., K. S. Warmington, J. H. Ruth, P. S. Sanghi, P. Lincoln, and S. L. Kunkel. 1996. Role of monocyte chemoattractant protein-1 (MCP-1) in Thl (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J. Immunol. 157: 4602–4608.
Fuentes, M. E., S. K. Durham, M. R. Swerdel, A. C. Lewin, D. S. Barton, J. R. Megill, R. Bravo, and S. A. Lira. 1995. Controlled recruitment of monocytes/macrophages to specific organs through transgenic expression of MCP-1. J. Immunol. 155: 5769–5776.
Gunn, M. D., N. A. Nelken, X. Liao, and L. T. Williams. 1997. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol. 158: 376–383.
Nakamura, K., I. R. Williams, and T. S. Kupper. 1995. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J. Invest. Dermatol. 105: 635–643.
Sozzani, S., F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. Van Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani. 1995. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155: 3292–3295.
Xu, L. L., M. K. Warren, W. L. Rose, W. Gong, and J. M. Wang. 1996. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. Leuk. Biol. 60 (3): 365–371.
Grewal, I. S., B. J. Rutledge, J. A. Fiorillo, L. Gu, R. P. Gladue, R. A. Flavell, and B. J. Rollins. 1997. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 159: 401–408.
Olin, S., G. LaRosa, J. J. Campbell, H. Smith-Heath, N. Kassam, X. Shi, L. Zeng, E. C. Buthcher, and C. R. Mackay. 1996. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur. J. Immunol. 26: 640–647.
Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Activation of NK cells by CC chemokines: chemotaxis, Ca2+ mobilization, and enzyme release. J. Immunol. 156: 322–327.
Tangirala, R. K., K. Murao, and O. Quehenberger. 1997. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J. Biol. Chem. 272: 8050–8056.
Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78: 1112–1116.
Rollins, B. J., and M. E. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11: 3125–3131.
Kaufman, R. J., P. Murtha, and M. Davies. 1987. Translational efficiency of polycistronic mRNAs and their utilization to express heterologous genes in mammalian cells. EMBO J. 6: 187–193.
Walter, S., B. Bottazzi, D. Govoni, F. Colotta, and A. Mantovani. 1991. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 49: 431–435.
Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148: 1280–1285.
Yamashira, S., M. Takeya, T. Nishi, J. Kuratsu, T. Yoshimura, Y. Ushio, and K. Takahashi. 1994. Tumor derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am. J. Pathol. 145: 856–867.
Huang, S., R. K. Singh, K. Xie, M. Gutman, K. K. Berry, C. D. Bucana, I. J. Fidler, and M. Bar-Eli. 1994. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother. 39: 231–238.
Negus, R. P., G. W. Stamp, J. Hadley, and F. R. Balkwill. 1997. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150: 1723–1734.
Zhang, L., A. Khayat, H. Cheng, and D. T. Graves. 1997. The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth. Lab. Invest. 76: 579–590.
Manome, Y., P. Y. Wen, A. Hershowitz, T. Tanaka, B. J. Rollins, D. W. Kufe, and H. A. Fine. 1995. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41: 227–235.
Singh, R. K., K. Berry, K. Matsushima, K. Yasumoto, and I. J. Fidler. 1993. Synergism between human monocyte chemotactic and activating factor and bacterial products for activation of tumoricidal properties in murine macrophages. J. Immunol. 151: 2786–2793.
Nishioka, Y., S. Yano, F. Fujiki, N. Mukaida, K. Matsushima, T. Tsuruo, and S. Sone. 1997. Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance. Int. J. Cancer 71: 170–177.
Brooks, W. H., M. G. Netsky, D. E. Normansell, and D. A. Horwitz. 1972. Depressed cell-mediated immunity in patients with primary intracranial tumors: characterization of a humoral immunosuppressive factor. J. Exp. Med. 136: 1631–1647.
Kuratsu, J., K. Yoshizato, T. Yoshimura, E. J. Leonard, H. Takeshima, and Y. Ushio. 1993. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J. Natl. Cancer Inst. 85: 1836–1839.
Boetcher, D. A., and E. J. Leonard. 1974. Abnormal monocyte chemotactic response in cancer patients. J. Natl. Cancer Inst. 52: 1091–1099.
Snyderman, R., M. C. Pike, L. Meadows, G. Hemstreet, and S. Wells. 1975. Depression of monocyte chemotaxis by neoplasia. Clin. Res. 34: 297A.
Normann, S. J., and E. Sorkin. 1977. Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro. Cancer Res. 37: 705–711.
Goldsmith, H. S., A. G. Levin, and C. M. Southam. 1965. A study of cellular responses in cancer patients by qualitative and quantitative Rebuck tests. Surg. Forum 16: 102–104.
Dizon, Q. S., and C. M. Southam. 1963. Abnormal cellular response to skin abrasion in cancer patients. Cancer 16: 1288–1292.
Snyderman, R., M. C. Pike, B. L. Blaylock, and P. Weinstein. 1976. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J. Immunol. 116: 585–589.
North, R. J., D. P. Kirstein, and R. L. Tuttle. 1976. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J. Exp. Med. 143: 559–573.
Takeshima, H., J. Kuratsu, M. Takeya, T. Yoshimura, and Y. Ushio. 1994. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J. Neurosurg. 80: 1056–1062.
Furutani, Y., H. Nomura, M. Notake, Y. Oyamada, T. Fukui, M. Yamada, C. G. Larsen, J. J. Oppenheim, and K. Matsushima. 1989. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. Biophys. Res. Commun. 159: 249–255.
Van Damme, J., B. Decock, J. P. Lenaerts, R. Conings, R. Bertini, A. Montovani, and A. Billau. 1989. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur. J. Immunol. 19: 2367–2373.
Negus, R. P., G. W. Stamp, M. G. Relf, F. Burke, S. T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani, and F. R. Balkwill. 1995. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95: 2391–2396.
Sonouchi, K., T. A. Hamilton, C. S. Tannenbaum, R. R. Tubbs, R. Bukowski, and J. H. Finke. 1994. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with Interferon-a and Interleukin-2. Am. J. Pathol. 144: 747–755.
Melani, C., S. M. Pupa, A. Stoppacciaro, S. Menard, M. I. Colnaghi, G. Parmiani, and M. P. Colombo. 1995. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int. J. Cancer 62: 572–578.
Graves, D. T., R. Barnhill, T. Galanopoulos, and H. N. Antoniades. 1992. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 140: 9–14.
Takeya, M., T. Yoshimura, E. J. Leonard, T. Kato, H. Okabe, and K. Takahashi. 1991. Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma: relation to the origin of histiocyte-like cells. Exp. Mol. Pathol. 54: 61–71.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rollins, B.J., Fine, H.A., Gu, L., Soejima, K., Tseng, S. (1999). Tumor Infiltration by Monocytes and the Antitumor Effects of Monocyte Chemoattractant Protein-1. In: Rollins, B.J. (eds) Chemokines and Cancer. Contemporary Cancer Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-701-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-701-7_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-4760-7
Online ISBN: 978-1-59259-701-7
eBook Packages: Springer Book Archive